Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension (Q42278661)
Jump to navigation
Jump to search
scientific article published on April 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension |
scientific article published on April 1995 |
Statements
1 reference
Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension (English)
1 reference
Goldberg AI
1 reference
Dunlay MC
1 reference
Sweet CS
1 reference
1 April 1995
1 reference
1 reference
75
1 reference
12
1 reference
793-795
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference